Dariohealth Corp Stock Analysis
| DRIO Stock | USD 0.69 0.01 1.43% |
DarioHealth Corp is undervalued with Real Value of 1.1 and Target Price of 2.38. The main objective of DarioHealth Corp stock analysis is to determine its intrinsic value, which is an estimate of what DarioHealth Corp is worth, separate from its market price. There are two main types of DarioHealth Corp's stock analysis: fundamental analysis and technical analysis.
The DarioHealth Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. DarioHealth Corp is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. DarioHealth Stock trading window is adjusted to America/New York timezone.
DarioHealth | Build AI portfolio with DarioHealth Stock |
DarioHealth Stock Analysis Notes
About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 0.55. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 18th of November 2019. DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. To learn more about DarioHealth Corp call Erez Raphael at 972 4 770 6377 or check out https://www.dariohealth.com.DarioHealth Corp Investment Alerts
| DarioHealth Corp generated a negative expected return over the last 90 days | |
| DarioHealth Corp has some characteristics of a very speculative penny stock | |
| DarioHealth Corp has high historical volatility and very poor performance | |
| DarioHealth Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 27.04 M. Net Loss for the year was (42.75 M) with profit before overhead, payroll, taxes, and interest of 19.46 M. | |
| DarioHealth Corp currently holds about 67.95 M in cash with (38.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| DarioHealth Corp has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: DarioHealth Appoints Steven M. Nelson as President - TipRanks |
DarioHealth Corp Upcoming and Recent Events
Earnings reports are used by DarioHealth Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
DarioHealth Largest EPS Surprises
Earnings surprises can significantly impact DarioHealth Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-03-31 | -0.5 | -0.45 | 0.05 | 10 | ||
2023-08-10 | 2023-06-30 | -0.52 | -0.58 | -0.06 | 11 | ||
2025-05-13 | 2025-03-31 | -0.21 | -0.1188 | 0.0912 | 43 |
DarioHealth Corp Thematic Classifications
In addition to having DarioHealth Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French |
DarioHealth Stock Institutional Investors
| Shares | Lpl Financial Corp | 2025-03-31 | 108.5 K | State Street Corp | 2025-03-31 | 75 K | Northern Trust Corp | 2025-03-31 | 61.5 K | Wellspring Financial Advisors, Llc | 2025-03-31 | 50 K | Ubs Group Ag | 2025-03-31 | 46 K | Two Sigma Securities, Llc | 2025-03-31 | 30.5 K | Northwestern Mutual Wealth Management Co | 2025-03-31 | 30.4 K | Clarity Capital Partners Llc | 2025-03-31 | 28.2 K | The Colony Group Llc | 2025-03-31 | 24 K | Nantahala Capital Management, Llc | 2025-03-31 | 1.7 M | Appian Way Asset Management | 2025-03-31 | 1.3 M |
DarioHealth Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.34 M.DarioHealth Profitablity
The company has Profit Margin (PM) of (1.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.39.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.00) | (1.05) | |
| Return On Capital Employed | (0.56) | (0.59) | |
| Return On Assets | (0.36) | (0.38) | |
| Return On Equity | (0.59) | (0.56) |
Management Efficiency
DarioHealth Corp has return on total asset (ROA) of (0.2404) % which means that it has lost $0.2404 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5905) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of July 2025, Return On Tangible Assets is likely to drop to -1.05. In addition to that, Return On Capital Employed is likely to drop to -0.59. At this time, DarioHealth Corp's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.07 | 1.13 | |
| Tangible Book Value Per Share | (0.06) | (0.07) | |
| Enterprise Value Over EBITDA | (1.10) | (1.15) | |
| Price Book Value Ratio | 0.73 | 0.70 | |
| Enterprise Value Multiple | (1.10) | (1.15) | |
| Price Fair Value | 0.73 | 0.70 | |
| Enterprise Value | 55.2 M | 29 M |
The operational strategies employed by DarioHealth Corp management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Technical Drivers
As of the 21st of July, DarioHealth Corp shows the Coefficient Of Variation of 3323.96, mean deviation of 2.49, and Downside Deviation of 4.34. DarioHealth Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.DarioHealth Corp Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of DarioHealth Corp for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out DarioHealth Corp short-term fluctuations and highlight longer-term trends or cycles.
DarioHealth Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DarioHealth Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on DarioHealth Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DarioHealth Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DarioHealth Corp Outstanding Bonds
DarioHealth Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DarioHealth Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DarioHealth bonds can be classified according to their maturity, which is the date when DarioHealth Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| DARLING INGREDIENTS INC Corp BondUS237266AH40 | View | |
| DAR 6 15 JUN 30 Corp BondUS237266AJ06 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
DarioHealth Corp Predictive Daily Indicators
DarioHealth Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DarioHealth Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
DarioHealth Corp Forecast Models
DarioHealth Corp's time-series forecasting models are one of many DarioHealth Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DarioHealth Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About DarioHealth Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how DarioHealth Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DarioHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DarioHealth Corp. By using and applying DarioHealth Stock analysis, traders can create a robust methodology for identifying DarioHealth entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.65) | (1.73) | |
| Operating Profit Margin | (2.14) | (2.24) | |
| Net Loss | (1.58) | (1.66) | |
| Gross Profit Margin | 0.49 | 0.52 |
Current DarioHealth Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. DarioHealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. DarioHealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 2.38 | Strong Buy | 4 | Odds |
Most DarioHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DarioHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DarioHealth Corp, talking to its executives and customers, or listening to DarioHealth conference calls.
DarioHealth Stock Analysis Indicators
DarioHealth Corp stock analysis indicators help investors evaluate how DarioHealth Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading DarioHealth Corp shares will generate the highest return on investment. By understating and applying DarioHealth Corp stock analysis, traders can identify DarioHealth Corp position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 36.8 M | |
| Long Term Debt | 23.5 M | |
| Common Stock Shares Outstanding | 67.2 M | |
| Total Stockholder Equity | 72 M | |
| Total Cashflows From Investing Activities | -8.9 M | |
| Tax Provision | -1.9 M | |
| Property Plant And Equipment Net | 1.8 M | |
| Cash And Short Term Investments | 28.5 M | |
| Cash | 27.8 M | |
| Accounts Payable | 3 M | |
| Net Debt | 2.4 M | |
| 50 Day M A | 0.7001 | |
| Total Current Liabilities | 16.6 M | |
| Other Operating Expenses | 84.8 M | |
| Non Current Assets Total | 78.4 M | |
| Non Currrent Assets Other | 651 K | |
| Stock Based Compensation | 15.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share | Quarterly Revenue Growth 0.173 | Return On Assets | Return On Equity |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.